Dr. Martens (LON:DOCS) Insider Giles Wilson Purchases 167 Shares

Key Points

• Giles Wilson, an insider at Dr. Martens, purchased 167 shares at an average price of GBX 90, totaling £150.30, on September 11th.
• In addition to his latest purchase, he bought 105,838 shares and sold 30,000 shares on September 1st, indicating a significant trading activity.
• Dr. Martens has recently received a "buy" rating from Peel Hunt, while other analysts maintain a mixed stance with an average target price of GBX 6,000.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson bought 167 shares of the business's stock in a transaction on Thursday, September 11th. The stock was bought at an average price of GBX 90 per share, for a total transaction of £150.30.

Giles Wilson also recently made the following trade(s):

• On Monday, September 1st, Giles Wilson bought 105,838 shares of Dr. Martens stock. The stock was bought at an average price of GBX 91 per share, for a total transaction of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The shares were sold at an average price of GBX 91, for a total value of £27,300.
• On Monday, September 1st, Giles Wilson purchased 30,019 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 91 per share, with a total value of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total value of £95,206.50.
• On Monday, August 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 77 per share, with a total value of £149.38.
• On Friday, July 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 77 per share, with a total value of £149.38.

Dr. Martens Price Performance

Shares of LON DOCS opened at GBX 92.63 on Tuesday. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a market cap of £894.45 million, a PE ratio of 18,525.00, a P/E/G ratio of 6.40 and a beta of 0.11. The business has a 50-day simple moving average of GBX 83.29 and a two-hundred day simple moving average of GBX 68.15. Dr. Martens plc has a fifty-two week low of GBX 43.02 and a fifty-two week high of GBX 96.50.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Peel Hunt raised Dr. Martens to a "buy" rating in a report on Monday, August 18th. Royal Bank Of Canada decreased their target price on Dr. Martens from GBX 7,000 to GBX 6,000 and set a "sector perform" rating for the company in a report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.